Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

NS5A resistance leading to failure of 24-week therapy with sofosbuvir/ledipasvir and ribavirin for the treatment of hepatitis C genotype 1a infection in a HIV-1 co-infected patient.

Sevastianova K, Dean J, Bannan C, Coghlan M, Farrell G, Murray C, De Gascun CF, Bergin C.

J Clin Virol. 2016 Sep;82:66-9. doi: 10.1016/j.jcv.2016.06.012. Epub 2016 Jun 23.

PMID:
27454231
2.

High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme.

Gray E, O'Leary A, Stewart S, Bergin C, Cannon M, Courtney G, Crosbie O, De Gascun CF, Fanning LJ, Feeney E, Houlihan DD, Kelleher B, Lambert JS, Lee J, Mallon P, McConkey S, McCormick A, McKiernan S, McNally C, Murray F, Sheehan G, Norris S; Irish Hepatitis C Outcomes and Research Network (ICORN).

J Hepatol. 2016 Aug;65(2):446-8. doi: 10.1016/j.jhep.2016.03.022. Epub 2016 Apr 27. No abstract available.

PMID:
27130842
3.

Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe.

Broberg E, Melidou A, Prosenc K, Bragstad K, Hungnes O; WHO European Region and the European Influenza Surveillance Network members of the reporting countries.

Euro Surveill. 2016;21(13). doi: 10.2807/1560-7917.ES.2016.21.13.30184.

PMID:
27074657
4.

Cytomegalovirus Infection in Ireland: Seroprevalence, HLA Class I Alleles, and Implications.

Hassan J, O'Neill D, Honari B, De Gascun C, Connell J, Keogan M, Hickey D.

Medicine (Baltimore). 2016 Feb;95(6):e2735. doi: 10.1097/MD.0000000000002735.

5.

Naturally occurring HCV NS5A/B inhibitor resistance-associated mutations to direct-acting antivirals.

Nguyen LT, Hall N, Sheerin D, Carr M, De Gascun CF; Irish Hepatitis C Outcomes Research Network.

Antivir Ther. 2016 Jan 20. doi: 10.3851/IMP3025. [Epub ahead of print]

PMID:
26789637
6.

Pregnancy Outcomes of Mothers with Detectable CMV-Specific IgM Antibodies: A Three-Year Review in a Large Irish Tertiary Referral Maternity Hospital.

Drew RJ, Stapleton P, Abu H, Healy E, Ferguson W, De Gascun C, O'Gorman J, Eogan M.

Infect Dis Obstet Gynecol. 2015;2015:218080. doi: 10.1155/2015/218080. Epub 2015 Nov 30. Review.

7.

Mumps outbreaks in a highly vaccinated population: Investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus.

Kenny L, O'Kelly E, Connell J, De Gascun C, Hassan J.

J Clin Virol. 2016 Jan;74:8-12. doi: 10.1016/j.jcv.2015.11.023. Epub 2015 Nov 19.

PMID:
26630067
8.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DA, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CA, Schmit JC, Wensing AM; SPREAD Program.

Clin Infect Dis. 2016 Mar 1;62(5):655-63. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

9.

Injection of new psychoactive substance snow blow associated with recently acquired HIV infections among homeless people who inject drugs in Dublin, Ireland, 2015.

Giese C, Igoe D, Gibbons Z, Hurley C, Stokes S, McNamara S, Ennis O, O'Donnell K, Keenan E, De Gascun C, Lyons F, Ward M, Danis K, Glynn R, Waters A, Fitzgerald M; outbreak control team.

Euro Surveill. 2015;20(40). doi: 10.2807/1560-7917.ES.2015.20.40.30036.

PMID:
26537764
10.

European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014.

Poelman R, Schuffenecker I, Van Leer-Buter C, Josset L, Niesters HG, Lina B; ESCV-ECDC EV-D68 study group.

J Clin Virol. 2015 Oct;71:1-9. doi: 10.1016/j.jcv.2015.07.296. Epub 2015 Jul 26.

11.

Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Kee PN, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW.

PLoS Med. 2015 Jun 1;12(6):e1001845. doi: 10.1371/journal.pmed.1001845. eCollection 2015 Jun. No abstract available.

12.

Hepatitis C Virus Core Mutations Associated with False-Negative Serological Results for Genotype 3a Core Antigen.

Nguyen LT, Dunford L, Freitas I, Holder P, Nguyen LA, O'Gorman J, Connell J, Carr M, Hall W, De Gascun C.

J Clin Microbiol. 2015 Aug;53(8):2697-700. doi: 10.1128/JCM.01062-15. Epub 2015 May 20.

13.

Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individuals.

Nguyen LT, Gray E, Dean J, Carr M, Connell J, De Gascun C, Nguyen LA, O'Leary A, Bergin C, Hall W, Norris S.

Antivir Ther. 2015;20(8):865-9. doi: 10.3851/IMP2964. Epub 2015 Apr 29.

PMID:
25920764
14.

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, Rinke de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW.

PLoS Med. 2015 Apr 7;12(4):e1001810. doi: 10.1371/journal.pmed.1001810. eCollection 2015 Apr. Erratum in: PLoS Med. 2015 Jun;12(6):e1001845.

15.

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.

Frentz D, Van de Vijver DA, Abecasis AB, Albert J, Hamouda O, Jørgensen LB, Kücherer C, Struck D, Schmit JC, Vercauteren J, Åsjö B, Balotta C, Beshkov D, Camacho RJ, Clotet B, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis LG, Liitsola K, Linka M, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Stanekova D, Stanojevic M, Van Wijngaerden E, Wensing AM, Boucher CA; SPREAD Programme.

BMC Infect Dis. 2014 Jul 21;14:407. doi: 10.1186/1471-2334-14-407.

16.
17.

Patterns of transmitted HIV drug resistance in Europe vary by risk group.

Frentz D, van de Vijver D, Abecasis A, Albert J, Hamouda O, Jørgensen L, Kücherer C, Struck D, Schmit JC, Vercauteren J, Asjö B, Balotta C, Bergin C, Beshkov D, Camacho R, Clotet B, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis L, Linka KL, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Stanekova D, Stanojevic M, Vandamme AM, Boucher C, Wensing A; SPREAD Programme.

PLoS One. 2014 Apr 10;9(4):e94495. doi: 10.1371/journal.pone.0094495. eCollection 2014.

18.

Management of ganciclovir-resistant cytomegalovirus retinitis in HIV infection in the era of antiretroviral therapy.

Adler H, De Gascun CF, McSweeney F, Acheson RW, Brannigan ET, Duffy M, Keegan DJ, Lambert JS.

Int J STD AIDS. 2014 Oct;25(11):827-9. doi: 10.1177/0956462414522773. Epub 2014 Feb 10.

PMID:
24516078
19.

Incidence of congenital cytomegalovirus infection in Ireland: implications for screening and diagnosis.

Waters A, Jennings K, Fitzpatrick E, Coughlan S, Molloy EJ, De Gascun CF, Hall WW, Knowles SJ.

J Clin Virol. 2014 Mar;59(3):156-60. doi: 10.1016/j.jcv.2013.12.007. Epub 2014 Jan 3.

PMID:
24461765
20.

Is universal screening for hepatitis C infection prior to commencing antitumour necrosis factor-α therapy necessary?

Reid CT, De Gascun C, Hall W, Collins P, Lally A, Kirby B.

Br J Dermatol. 2013 Dec;169(6):1319-21. doi: 10.1111/bjd.12598.

PMID:
24032395
Items per page

Supplemental Content

Loading ...
Write to the Help Desk